British medical journal The Lancet has concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.
Sanofi temporarily stopped recruiting new COVID-19 patients for two clinical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up.
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19 amid questions about the safety of the generic anti-malaria drug.
Questions over the efficacy and safety of hydroxychloroquine continue to be raised following the World Health Organization’s decision to temporarily halt a study of the malaria drug as a potential treatment for COVID-19.
A COVID-19 vaccine candidate under development by China’s CanSino Biologics is moving forward in development after the company published data supporting patient safety.
The U.S. Food and Drug Administration approved Marlborough, Massachusetts-based Sunovion Pharmaceuticals’ Kynmobi (apomorphine HCl) sublingual film for Parkinson’s disease.
The malaria drug hydroxychloroquine – which U.S. President Donald Trump says he has been taking – is tied to increased risk of death in COVID-19 patients, according to a study published in the medical journal Lancet.
BioSpace reviews some of the more interesting scientific studies recently published, including a Phase II clinical trial out of Hong Kong that found a three drug-antiviral cocktail significantly decreased median time to a negative SARS-CoV-2 test compared to controls.
Enzyme makes men more vulnerable to coronavirus; adding interferon may improve treatment
ACE2 (angiotensin-converting enzyme-2), Angiotensin Receptor Blockers (ARBs), Blood, Blood Pressure, Cells, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Enzymes, Europe, Hospitalizations, Pregnancies, Scientists, Studies, Sweden, The Lancet, United KingdomA brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Coronavirus Transmission: Where the Virus Goes in the Body and How SARS-CoV-2 is Spread
ACE2 (angiotensin-converting enzyme-2), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Dr. Anthony Fauci (Director), Human Body, Medical Journals, National Institute of Allergy and Infectious Diseases (NIAID), R&D, Researchers, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Lancet, World Health OrganizationA look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.